Antigen-mediated cross-linking of IgE-FcεRI complexes activates mast cells and basophils, initiating the allergic response. Of 34 donors recruited having self-reported shrimp allergy, only 35% had significant levels of shrimp-specific IgE in serum and measurable basophil secretory responses to recombinant Pen a 1 (shrimp tropomyosin). We report that degranulation is linked to the number of FcεRI occupied with allergen-specific IgE, as well as the dose and valency of Pen a 1. Using CRISPR-based gene editing, rat basophilic leukemia (hRBLrαKO) cells were created that exclusively express the hFcεRIα subunit. Pen a 1 specific-IgE (IgEPen a 1) was affinity purified from shrimp positive plasma. Cells primed with a range of IgEPen a 1 and challenged with Pen a 1 show a bell-shaped dose response for secretion, with optimal Pen a 1 doses of 0.1–10 ng/ml. Mathematical modeling provided estimates of receptor aggregation kinetics based upon FcεRI occupancy with IgE and allergen dose. Maximal degranulation was elicited when ~2700 IgE-FcεRI complexes were occupied with specific IgE and challenged with Pen a 1 (IgE epitope valency of 8+), although measurable responses were achieved with only a few hundred FcεRI were occupied. Prolonged periods of pepsin-mediated Pen a 1 proteolysis, which simulates gastric digestion, were required to diminish secretory responses. Recombinant fragments (60–79 amino acids), that together span the entire length of tropomyosin, were weak secretagogues. These fragments have reduced dimerization capacity, compete with intact Pen a 1 for binding to IgE-FcεRI complexes, and represent a starting point for the design of promising hypoallergens for immunotherapy.